Cargando…

Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma

Platform and study differences in prognostic signatures from metastatic melanoma (MM) gene expression reports often hinder consensus arrival. We performed survival/outcome-based pairwise comparisons of three independent MM gene expression profiles using the threshold-free algorithm rank-rank hyperge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lardone, Ricardo D., Plaisier, Seema B., Navarrete, Marian S., Shamonki, Jaime M., Jalas, John R., Sieling, Peter A., Lee, Delphine J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924725/ https://www.ncbi.nlm.nih.gov/pubmed/26883106 http://dx.doi.org/10.18632/oncotarget.7361

Ejemplares similares

Immune correlates of melanoma survival in adoptive cell therapy
por: Lee, Agnes Fermin, et al.
Publicado: (2013)

Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function
por: Lardone, Ricardo D., et al.
Publicado: (2017)

Microbial Dysbiosis Is Associated with Human Breast Cancer
por: Xuan, Caiyun, et al.
Publicado: (2014)

Beyond the immediate tumor microenvironment: distinct T cell phenotype and function of tumor-adjacent healthy breast tissue associated with regional metastasis in breast cancer
por: Guo, Yi, et al.
Publicado: (2014)

A gene expression signature associated with survival in metastatic melanoma
por: Mandruzzato, Susanna, et al.
Publicado: (2006)

Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer
por: Wistuba-Hamprecht, Kilian, et al.
Publicado: (2020)

Characterization of a Myeloid Activation Signature That Correlates with Survival in Melanoma Patients
por: Kremenovic, Mirela, et al.
Publicado: (2020)

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients
por: Herbreteau, Guillaume, et al.
Publicado: (2020)

FASTQSim: platform-independent data characterization and in silico read generation for NGS datasets
por: Shcherbina, Anna
Publicado: (2014)

Investigation of female survival benefit in metastatic melanoma
por: Richardson, B, et al.
Publicado: (1999)

Survival rates of patients with metastatic malignant melanoma
por: Sandru, A, et al.
Publicado: (2014)

Accelerated BRAF mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanoma
por: Serre, Delphine, et al.
Publicado: (2018)

Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma
por: Mangin, Marie‐Alix, et al.
Publicado: (2021)

γδ T cell activation may contribute to antitumor immunity stimulated by intralesional BCG immune therapy for cutaneous melanoma metastases
por: Ramos, Romela, et al.
Publicado: (2015)

Rank–rank hypergeometric overlap: identification of statistically significant overlap between gene-expression signatures
por: Plaisier, Seema B., et al.
Publicado: (2010)

Long-term Survival after Metastatic Childhood Melanoma
por: Larsen, Anne Kristine, et al.
Publicado: (2014)

A Gene Expression Signature of Invasive Potential in Metastatic Melanoma Cells
por: Jeffs, Aaron R., et al.
Publicado: (2009)

A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas
por: Chen, Rongyi, et al.
Publicado: (2014)

Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma
por: Bedin, Valcinir, et al.
Publicado: (2010)

Elevated serum levels of S100 and survival in metastatic malignant melanoma
Publicado: (1998)

Elevated serum levels of S100 and survival in metastatic malignant melanoma
Publicado: (1998)

Elevated serum levels of S100 and survival in metastatic malignant melanoma.
por: Buer, J., et al.
Publicado: (1997)

Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
por: Tas, Faruk
Publicado: (2012)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

Clinical determinants of long-term survival in metastatic uveal melanoma
por: Koch, Elias A. T., et al.
Publicado: (2021)

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi
por: Clarke, Loren E., et al.
Publicado: (2016)

Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer
por: Zhao, Shuang G., et al.
Publicado: (2015)

Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry
por: Jochems, Anouk, et al.
Publicado: (2019)

Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients
por: Xue, Meijuan, et al.
Publicado: (2019)

A twelve-gene signature for survival prediction in malignant melanoma patients
por: Song, Le-Bin, et al.
Publicado: (2020)

Tumor immunogenomic signatures improve a prognostic model of melanoma survival
por: Morales, Leah, et al.
Publicado: (2021)

Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets
por: De Cecco, Loris, et al.
Publicado: (2021)

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis
por: Krisp, Christoph, et al.
Publicado: (2018)

Survival analysis in breast cancer using proteomic data from four independent datasets
por: Ősz, Ágnes, et al.
Publicado: (2021)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
por: Piérard, Gérald E., et al.
Publicado: (2012)

Evolving impact of long-term survival results on metastatic melanoma treatment
por: Michielin, Olivier, et al.
Publicado: (2020)

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2020)

The immune cell landscape of metastatic uveal melanoma correlates with overall survival
por: Tosi, Anna, et al.
Publicado: (2021)

Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis
por: Gagliardi, Mara, et al.
Publicado: (2019)

Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients
por: Mactier, Swetlana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a1i01618phq94o0un38fml5a1t